Kane Biotech

Kane Biotech AAQS

The The AAQS of Kane Biotech (KNE.V) as of Oct 16, 2026 is 4. In the previous year, The AAQS was 4.00 — a change of 0.00% (lower).

AAQS

4

YoY

0.00%

Last updated:

Kane Biotech has a current AAQS of 4.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Kane Biotech in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Kane Biotech AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2018
4.00 CAD
Jan 1, 2019
4.00 CAD
Jan 1, 2020
4.00 CAD
Jan 1, 2021
4.00 CAD
Jan 1, 2022
4.00 CAD
Jan 1, 2023
4.00 CAD
Jan 1, 2024
4.00 CAD
Jan 1, 2025
4.00 CAD
The Kane Biotech AAQS history
YEARAAQSYoY
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
4—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Kane Biotech Stock analysis

What does Kane Biotech do? Kane Biotech Inc is a biotechnology company based in Winnipeg, Manitoba, Canada. The company went public on May 7, 2003, with its stock ticker KNE.V and ISIN CA4838092084. Kane Biotech focuses on researching, developing, and commercializing technologies and products designed to prevent and remove microbial biofilms. The company's product portfolio includes StrixNB, DispersinB, Aledex, bluestem (available in water additives, chews, spray, and dental wipes), silkstem, goldstem, coactiv+, and DermaKB Biofilm. Its Wound Care & Surgical division is developing DispersinB for chronic wound care applications. The company also offers products such as Scalp Detoxifier, Shampoo, and Shampoo Bars. Kane Biotech's primary market focus is on animal health, though it also develops products for human wound care and surgical applications. The company's product development includes Coactiv+ as an antimicrobial wound rinse and surgical hydrogel, as well as DispersinB Gel for prosthetic joint infections. Kane Biotech operates within the Health Care sector, specifically in the Biotechnology industry. The company's website is https://kanebiotech.com/ and it is headquartered in Winnipeg, Canada. Kane Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kane Biotech stock

The AAQS of Kane Biotech is 4 in 2025.

On Eulerpool you can find the complete historical development of The AAQS Kane Biotech since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Quality — Kane Biotech

AAQSPiotroski F-ScoreAltman Z-ScoreGraham NumberRule of 40

All Key Metrics — Kane Biotech